Cell
Volume 70, Issue 4, 21 August 1992, Pages 523-526
Minireviewp53 function and dysfunction
References (32)
- et al.
Cell
(1991) - et al.
Lancet
(1992) - et al.
Biochem. Biophys. Res. Commun.
(1992) - et al.
Cell
(1991) - et al.
Cell
(1992) - et al.
Cell
(1990) - et al.
J. Mol. Biol.
(1992) - et al.
Cancer Res.
(1990) - et al.
- et al.
Nature
(1992)
Nature Genet.
(1992)
EMBO J.
(1991)
Nature
(1992)
Science
(1990)
Mol. Cell. Biol.
(1992)
Cited by (2005)
Deregulated transcription factors and poor clinical outcomes in cancer patients
2022, Seminars in Cancer BiologyFatty acids and their lipid mediators in the induction of cellular apoptosis in cancer cells
2022, Prostaglandins and Other Lipid MediatorsCitation Excerpt :A high frequency of mutations of the p53 gene is the most common features found in most human cancers [98], and, in those tumors in which p53 itself is not mutated, other factors may modulate its function to render it inactive. p53 is a nuclear phosphoprotein whose inactivation, either through mutation, selective interaction with cellular MDM2 protein, viral oncogene products, or alteration in subcellular localization, is correlated strongly with human cancer [99–101]. If p53 is phosphorylated at Ser 15, interaction between MDM2 and p53 is decreased [102].
The influence of hypoxia on the cardiac transcriptomes of two estuarine species - C. variegatus and F. grandis
2021, Comparative Biochemistry and Physiology - Part D: Genomics and ProteomicsKaranjin, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell Lung Cancer Cells
2024, Anti-Cancer Agents in Medicinal Chemistry
Copyright © 1992